The Siconolfi step test: a valid and reliable assessment of cardiopulmonary fitness in older men with prostate cancer.

Cardiopulmonary fitness Clinical assessment Prehabilitation Prostate cancer Siconolfi step test

Journal

European review of aging and physical activity : official journal of the European Group for Research into Elderly and Physical Activity
ISSN: 1813-7253
Titre abrégé: Eur Rev Aging Phys Act
Pays: Germany
ID NLM: 101284836

Informations de publication

Date de publication:
2019
Historique:
received: 03 07 2018
accepted: 04 12 2018
entrez: 18 1 2019
pubmed: 18 1 2019
medline: 18 1 2019
Statut: epublish

Résumé

Assessing fitness and promoting regular physical activity can improve health outcomes and early recovery in prostate cancer. This is however, underutilised in clinical practice. The cardiopulmonary exercise test (CPET) is increasingly being used pre-treatment to measure aerobic capacity and peak oxygen consumption (VO Sixty-six men provided data for both SST and CPET. These data were used for validity analysis. 56 men provided SST data on both visits. These data were used for reliability analysis. SST provided valid prediction of the cardiopulmonary fitness in men > 60 years old. The average difference between CPET and SST was 0.64 ml/kg/min with non-significant positive bias towards CPET ( SST provides a valid and reliable alternative to CPET for the assessment of cardiopulmonary fitness in older men with prostate cancer. Caution is advised when assessing men 60 years old or younger because the VO

Sections du résumé

BACKGROUND BACKGROUND
Assessing fitness and promoting regular physical activity can improve health outcomes and early recovery in prostate cancer. This is however, underutilised in clinical practice. The cardiopulmonary exercise test (CPET) is increasingly being used pre-treatment to measure aerobic capacity and peak oxygen consumption (VO
RESULTS RESULTS
Sixty-six men provided data for both SST and CPET. These data were used for validity analysis. 56 men provided SST data on both visits. These data were used for reliability analysis. SST provided valid prediction of the cardiopulmonary fitness in men > 60 years old. The average difference between CPET and SST was 0.64 ml/kg/min with non-significant positive bias towards CPET (
CONCLUSIONS CONCLUSIONS
SST provides a valid and reliable alternative to CPET for the assessment of cardiopulmonary fitness in older men with prostate cancer. Caution is advised when assessing men 60 years old or younger because the VO

Identifiants

pubmed: 30651889
doi: 10.1186/s11556-018-0207-9
pii: 207
pmc: PMC6327593
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1

Déclaration de conflit d'intérêts

This study was approved by NHS Health Research Authority (REC Ref 14/lo/0495) and Trust R&D at Royal Surrey Hospital NHS Trust and Newcastle upon Tyne NHS Foundation Trust. The study was supported by National Institute for Health Clinical Research Network (Study ID 16936). All participants provided informed, written consent.Not applicable.AL, KP, SF report grants from Movember Foundation and Prostate Cancer UK during the conduct of the study; JA, BG, RM, JS, JW declare no conflicts of interest; SF is a trustee of Prostate Cancer UK.Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Références

Support Care Cancer. 2016 May;24(5):2277-2285
pubmed: 26590843
Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007566
pubmed: 22895961
J Clin Oncol. 2011 Apr 1;29(10):1335-41
pubmed: 21357791
J Appl Physiol (1985). 2003 Nov;95(5):1851-60
pubmed: 14555665
Eur J Cancer Care (Engl). 2014 Mar;23(2):199-205
pubmed: 24127843
J Sci Med Sport. 2005 Mar;8(1):61-70
pubmed: 15887902
JAMA Intern Med. 2016 Jan;176(1):87-95
pubmed: 26618471
Can Med Assoc J. 1976 Apr 17;114(8):680-2
pubmed: 1260614
Am J Cardiol. 2017 Feb 1;119(3):497-500
pubmed: 27884421
J Am Heart Assoc. 2014 Jan 13;3(1):e000432
pubmed: 24419734
Eur J Cancer Care (Engl). 2017 Nov;26(6):
pubmed: 28169490
BMC Res Notes. 2011 Apr 14;4:127
pubmed: 21492469
Nat Rev Clin Oncol. 2012 Mar 06;9(5):288-96
pubmed: 22392097
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Sports Med. 2004;34(6):363-9
pubmed: 15157121
ESMO Open. 2016 Apr 12;1(3):e000020
pubmed: 27843603
Eur Urol. 2016 Apr;69(4):693-703
pubmed: 26632144
Anticancer Drugs. 2017 Jan;28(1):104-109
pubmed: 27579728
Med Sci Sports Exerc. 2010 Jul;42(7):1409-26
pubmed: 20559064
Rev Med Chil. 2012 Sep;140(9):1164-9
pubmed: 23354638
CA Cancer J Clin. 2012 Jul-Aug;62(4):243-74
pubmed: 22539238
J Cancer Surviv. 2015 Sep;9(3):500-11
pubmed: 25876555
Cancer Causes Control. 2001 Jun;12(5):461-75
pubmed: 11545461
Anaesthesia. 2009 Aug;64(8):883-93
pubmed: 19604193
J Appl Physiol. 1954 Sep;7(2):218-21
pubmed: 13211501
Epidemiology. 2007 Jan;18(1):137-57
pubmed: 17130685
Eur J Cancer. 2007 Jan;43(1):14-34
pubmed: 17222747
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Can Fam Physician. 1999 Apr;45:992, 995, 1004-5
pubmed: 10216799
Can Urol Assoc J. 2014 Nov;8(11-12):418-23
pubmed: 25553155
J Physiother. 2014 Sep;60(3):144-50
pubmed: 25084634
Cardiooncology. 2017 Mar 13;3:3
pubmed: 32153999
Phys Ther. 2000 Aug;80(8):782-807
pubmed: 10911416
BJU Int. 2017 Dec;120(6):751-754
pubmed: 28834013
Med Sci Sports Exerc. 1996 Jan;28(1):97-104
pubmed: 8775361
Oncologist. 2012;17 Suppl 1:4-8
pubmed: 23015679
Am J Epidemiol. 1985 Mar;121(3):382-90
pubmed: 4014128
J Clin Oncol. 2017 Aug 10;35(23):2604-2612
pubmed: 28586243
Int J Public Health. 2013 Dec;58(6):949-53
pubmed: 23974352
Med Sci Sports Exerc. 2015 Jan;47(1):27-32
pubmed: 24781891
Acta Oncol. 2016 Jan;55(1):15-23
pubmed: 26271800
Lancet Oncol. 2014 Aug;15(9):e404-14
pubmed: 25079103
Br J Sports Med. 2004 Apr;38(2):197-205
pubmed: 15039259
Eur Urol. 2017 Aug;72(2):293-299
pubmed: 28249801
J Natl Cancer Inst. 2015 Nov 17;108(3):
pubmed: 26577654
Indian J Anaesth. 2011 Mar;55(2):111-5
pubmed: 21712864
Recent Results Cancer Res. 2011;186:13-42
pubmed: 21113759
Med Sci Sports Exerc. 1982;14(5):335-8
pubmed: 7154887
J Cancer Surviv. 2010 Jun;4(2):87-100
pubmed: 20052559
Br J Anaesth. 2000 Jul;85(1):109-17
pubmed: 10927999
Arthritis Rheum. 2007 Aug 15;57(6):1007-11
pubmed: 17665489
Int J Rheumatol. 2013;2013:174541
pubmed: 24454385
Ann R Coll Surg Engl. 2011 Apr;93(3):185-7
pubmed: 21477427
Eur J Oncol Nurs. 2011 Jul;15(3):213-20
pubmed: 20674499
Eur J Vasc Endovasc Surg. 2012 Jul;44(1):64-71
pubmed: 22521839
Eur Respir J. 2005 Jun;25(6):1057-60
pubmed: 15929962

Auteurs

Agnieszka Lemanska (A)

1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Karen Poole (K)

1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Jonathan J Aning (JJ)

2Department of Urology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
3Bristol Urological Institute, Southmead Hospital, Westbury-on-trym, Bristol, UK.

Bruce A Griffin (BA)

1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Ralph Manders (R)

1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

John M Saxton (JM)

4Department of Sport, Exercise & Rehabilitation, Northumbria University, Newcastle Upon Tyne, UK.

Joe Wainwright (J)

1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Sara Faithfull (S)

1Faculty of Health and Medical Sciences, University of Surrey, Guildford, UK.

Classifications MeSH